IFNB1 and Alzheimer disease: However, to establish a definitive causal link between IFN-β and brain endothelial barrier integrity in the AD model, it would be necessary to perform genetic studies with endothelial specific deletion of the Type I interferon receptor in vivo, and then assess whether this restores the brain endothelial barrier integrity in the AD mouse model.